Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats
- PMID: 17805418
- PMCID: PMC1964906
- DOI: 10.1289/ehp.10271
Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats
Abstract
Background: In a previous study conducted at the Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation (CMCRC/ERF), we demonstrated for the first time that aspartame (APM) is a multipotent carcinogenic agent when various doses are administered with feed to Sprague-Dawley rats from 8 weeks of age throughout the life span.
Objective: The aim of this second study is to better quantify the carcinogenic risk of APM, beginning treatment during fetal life.
Methods: We studied groups of 70-95 male and female Sprague-Dawley rats administered APM (2,000, 400, or 0 ppm) with feed from the 12th day of fetal life until natural death.
Results: Our results show a) a significant dose-related increase of malignant tumor-bearing animals in males (p < 0.01), particularly in the group treated with 2,000 ppm APM (p < 0.01); b) a significant increase in incidence of lymphomas/leukemias in males treated with 2,000 ppm (p < 0.05) and a significant dose-related increase in incidence of lymphomas/leukemias in females (p < 0.01), particularly in the 2,000-ppm group (p < 0.01); and c) a significant dose-related increase in incidence of mammary cancer in females (p < 0.05), particularly in the 2,000-ppm group (p < 0.05).
Conclusions: The results of this carcinogenicity bioassay confirm and reinforce the first experimental demonstration of APM's multipotential carcinogenicity at a dose level close to the acceptable daily intake for humans. Furthermore, the study demonstrates that when life-span exposure to APM begins during fetal life, its carcinogenic effects are increased.
Keywords: Sprague-Dawley; artificial sweeteners; aspartame; carcinogenicity; lymphomas/leukemias; mammary cancers; prenatal exposure.
Figures
Comment in
-
Carcinogenicity of aspartame in rats not proven.Environ Health Perspect. 2008 Jun;116(6):A239-40; author reply A240. doi: 10.1289/ehp.10881. Environ Health Perspect. 2008. PMID: 18560494 Free PMC article. No abstract available.
References
-
- American Dietetic Association. Position of the American Dietetic Association: use of nutritive and nonnutritive sweeteners. J Am Diet Assoc. 2004;104:225–275. - PubMed
-
- Aspartame Information Center. Aspartame Information Center Homepage. 2005. [accessed 27 October 2005]. Available: http://www.aspartame.org.
-
- Belpoggi F, Soffritti M, Bua L, Guarino M, Lambertini L, Cevolani D, et al. Results of long-term experimental studies on the carcinogenicity of ethylene-bis-dithiocarba-mate (Mancozeb) in rats. Ann NY Acad Sci. 2002a;982:123–136. - PubMed
-
- Belpoggi F, Soffritti M, Maltoni C. Methyl-tertiary-butyl ether (MTBE), a gasoline additive, causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Health. 1995;11:119–149. - PubMed
-
- Belpoggi F, Soffritti M, Minardi F, Bua L, Cattin E, Maltoni C. Results of long-term carcinogenicity bioassays on tert-amyl-methyl-ether (TAME) and di-isopropyl-ether (DIPE) in rats. Ann NY Acad Sci. 2002b;982:70–86. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
